Israel's Health Ministry has identified fewer than 10 cases of heart inflammation following a third dose of the Pfizer/BioNtech vaccine among millions administered, Reuters cites official data as revealing.
Israel began administering boosters to risk groups in July and by the end of August expanded its campaign to include anyone above the age of 12, five months or more after a second dose.
In data published late on Thursday, the Health Ministry reported nine cases of myocarditis within four age groups that comprised more than 1.5 million people who had received a booster shot.
